General Considerations for Clinical Trials

  • TRANSMISSION TO CPMP (COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE)
  • TRANSMISSION TO INTERESTED PARTIES
  • DEADLINE FOR COMMENTS
  • FINAL APPROVAL BY CPMP (COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE)
  • DATE FOR COMING INTO OPERATION

Related Conference of General Considerations for Clinical Trials

General Considerations for Clinical Trials Conference Speakers